TB patients with low DNA methylation levels over +982 CpG site of the MRPS18B gene (<48%, n = 35) had lower one-year survival (all-cause mortality rate 14.28% versus 0%, p = 0.021 by log-rank test, Figure 3c) than those with high methylation levels (≥48%, n = 29). This evidence concerns the gene MRPS18B and tuberculosis.